Lopressor: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 20: | Line 20: | ||
===[[Lopressor pediatric indications and dosage#Off-Label Use and Dosage|Off-Label Use and Dosage (Pediatric)]]=== | ===[[Lopressor pediatric indications and dosage#Off-Label Use and Dosage|Off-Label Use and Dosage (Pediatric)]]=== | ||
==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ||
Line 36: | Line 34: | ||
==[[Lopressor pregnancy category|Pregnancy Category]]== | ==[[Lopressor pregnancy category|Pregnancy Category]]== | ||
==[[Lopressor adverse reactions|Adverse Reactions]]== | |||
==[[Lopressor drug interactions|Drug Interactions]]== | ==[[Lopressor drug interactions|Drug Interactions]]== | ||
===[[Lopressor adverse reactions#Clinical Trials Experience|Clinical Trials Experience]]=== | ===[[Lopressor adverse reactions#Clinical Trials Experience|Clinical Trials Experience]]=== |
Revision as of 17:47, 17 March 2014
![]() | |
Clinical data | |
---|---|
Trade names | Lopressor, Toprol-xl |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682864 |
[[Regulation of therapeutic goods |Template:Engvar data]] |
|
Pregnancy category | |
Routes of administration | Oral, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 12% |
Metabolism | Hepatic via CYP2D6, CYP3A4 |
Elimination half-life | 3-7 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C15H25NO3 |
Molar mass | 267.364 g/mol |
3D model (JSmol) | |
Melting point | 120 °C (248 °F) |
| |
| |
(verify) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For information about metoprolol, click here.
Disclaimer
Black Box Warning
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Off-Label Use and Dosage (Adult)
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Off-Label Use and Dosage (Pediatric)
FDA-Labeled Indications
Off-Label Use
Contraindications
Warnings and Precautions
Warnings
Precautions
Pregnancy Category
Adverse Reactions
Drug Interactions
Clinical Trials Experience
Postmarketing Experience
Mechanism of Action
Forms and Administration
Forms
Administration
Use in Specific Populations
Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Geriatric Use
Gender
Race
Renal Impairment
Hepatic Impairment
Females of Reproductive Potential and Males
Immunocompromised Patients
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Price
Pill Images and Characteristics
Look-Alike Drug Names
IV compatibility
Categories:
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Antianginals
- Antiarrhythmic agents
- Antihypertensive agents
- Antimigraine drugs
- Beta blockers
- Cardiovascular Drugs